TrialInvestigational new drugs2018

Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy.

Seiko Bun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.